University of Kent
The programme is designed for graduates with a biological background and builds on existing core biosciences modules in the area of applied biotechnology. It gives a grounding in the early stage drug discovery process for those interested in careers in biotechnology or the pharmaceutical industry. The course covers application of technologies to early stage drug discovery focusing on target identification, target validation, and lead discovery and design follow-up through understanding protein ligand interactions and biophysics at a molecular level in order to produce good drug candidate molecules via rational drug design. The programme also includes site visits to biotechnology companies and industry, plus workshops/lectures from invited industrial experts.visits to biotechnology companies and industry, plus workshops/lectures from invited industrial experts.
A minimum 2nd class Honours degree in a biosciences-related subject.
Assessment is by coursework, examination and dissertation.
|Qualification||Study mode||Fee||Course duration|
|MSc||Full-time||£ 5,250 per Academic year (home fees)||1 years|
|MSc||Full-time||£ 12,890 per Academic year (overseas fees)||1 years|
|MSc||Part-time||£ 2,625 per Academic year (home fees)||2 years|
|MSc||Part-time||£ 6,460 per Academic year (overseas fees)||2 years|
|Campus name||Town||Postcode||Region||Main campus||Campus||Partner|
|Canterbury Campus||Canterbury||CT2 7NZ||South East|
School of Biosciences